Mirexus Biotechnologies Relocates to New Facility in Guelph

Mirexus Biotechnologies is pleased to announce that we have relocated to our new building at 574 Hanlon Creek Boulevard, Guelph, Ontario (the corner of Hanlon Creek Blvd. and Downey Rd.). The building includes expanded lab space (to develop new personal care, nutraceutical, and biomedical applications) and offices, and most importantly a first-generation factory, designed to produce 16T / year of PhytoSpherix® – Mirexus’ safe & natural nanomaterial.  The proprietary process uses only water and energy to extract this natural product from Ontario sweet corn. Dr. Phil Whiting, President and...

read more

Mirexus Biotechnologies chooses 100% green energy for entire operations with Bullfrog Power

Mirexus Biotechnologies is pleased to announce that we are now reducing our energy-related emissions footprint through a new commitment to renewable energy and choosing 100% green energy for entire operations with Bullfrog Power. The organization is choosing 100 per cent renewable electricity and green natural gas for its factory, lab and office in Guelph where it produces a sustainable nanomaterial used in cosmetic, nutraceutical and biomedical products. “At Mirexus, our commitment to sustainability runs through all aspects of our business,” says Phil Whiting, President and CEO, Mirexus....

read more

Mirexus Inc. Signs Strategic Partnership with Cargill Beauty

Guelph, Ontario – April 12th, 2018 – Mirexus Inc., a Canadian biotechnology company, and Cargill Beauty, the personal care platform within Cargill, have agreed to enter into a long term strategic partnership, allowing Cargill Beauty to deliver Mirexus’ innovative, natural bio-active – PhytoSpherix™ – to targeted Cargill customers in the Global Personal Care market. “This is a wonderful opportunity for Mirexus”, said Boris Segalowitch, President of Mirexus Inc.  “We needed to accelerate our growth and with Cargill Beauty as our partner in just one step we have moved into the big...

read more

Boris Segalowich appointed as President of Mirexus Inc.

Mirexus Biotechnologies Inc. (MBI) is pleased to announce the appointment of Boris Segalowich as President of Mirexus Inc.   Mirexus Inc. is a wholly owned subsidiary company of MBI, and is focused on applications of it’s unique, plant-based active ingredient PhytoSpherix® in the personal care industry. “Boris joined as VP Personal Care in June this year and has quickly demonstrated the skills and knowledge needed to lead this business”, says Phil Whiting, CEO of MBI.  “Our personal care business offers great growth potential for us, and needed his leadership and experience.” PhytoSpherix®...

read more

Mirexus Biotechnologies celebrated ground-breaking for new manufacturing facility

  On Thursday, September 28th Mirexus Biotechnologies hosted a ground-breaking ceremony to celebrate the commencement of construction of its new manufacturing and research facility in Guelph.  The building will include expanded lab space and offices, and most importantly a first-generation factory, designed to produce 16T / year of PhytoSpherix™ – Mirexus’ safe & natural nanomaterial.  The proprietary process uses only water and energy to extract this natural product from Ontario sweet corn. The ground-breaking ceremony was celebrated in the presence of Mayor Cam Guthrie,...

read more

Ricky Ghoshal joins Glysantis as Sr. Business Development Associate

Mirexus is pleased to announce that Ricky Ghoshal has joined Glysantis as Sr. Business Development Associate. Ricky recently completed an 8-month internship with Glysantis as part of McMaster University’s Master of Biomedical Discovery and Commercialization program. “Over the past 8-months Ricky has made considerable contributions to Glysantis. We are thrilled to have him join us full-time now that his program at McMaster is complete”, says Alison Crumblehulme, VP of Business Development. Ricky will support Glysantis’ commercialization efforts by conducting market research, identifying new...

read more